Homocysteine

Correcting elevated homocysteine addresses a direct mechanism of neurological degeneration. Normalizing B12, B6, folate, and zinc levels predictably reduces homocysteine. Methylcobalamin and methylfolate are the bioactive forms required to lower homocysteine; cyanocobalamin and folic acid are ineffective synthetic substitutes. Homocysteine above 12 µmol/L should trigger investigation into the underlying cause. The article presents homocysteine as a modifiable risk factor because it can be measured by blood test and lowered with B vitamins. Homocysteine must be cleared through methylation or trans-sulfuration pathways. Homocysteine is an amino acid that accumulates when B12, B6, and folate are insufficient, as these are the vitamins needed to process it through methylation pathways. B9 deficiency leads to elevated homocysteine levels through impaired homocysteine metabolism. Elevated homocysteine reflects impaired methylation, which requires vitamin B12 and folate in their active forms. B9 deficiency and impaired methylfolate production contribute to elevated homocysteine. Many people carry MTHFR genetic variants that prevent them from converting synthetic vitamin forms to active o…